Serious adverse events
|
Placebo |
Canagliflozin |
Total subjects affected by serious adverse events
|
|
|
subjects affected / exposed
|
775 / 2903 (26.70%) |
714 / 2904 (24.59%) |
number of deaths (all causes)
|
71 |
68 |
number of deaths resulting from adverse events
|
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
Acute Myeloid Leukaemia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Adenocarcinoma Gastric
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Adenocarcinoma of Colon
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Adenosquamous Cell Lung Cancer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
B-Cell Lymphoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
1 / 2 |
0 / 0 |
Basal Cell Carcinoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Lung Neoplasm
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Neoplasm
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Neoplasm of Thyroid Gland
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bile Duct Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Bladder Cancer
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
4 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bladder Cancer Recurrent
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bladder Transitional Cell Carcinoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bowen's Disease
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Adenoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Cancer
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Breast Cancer Metastatic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Breast Cancer Stage Ii
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Breast Cancer Stage Iii
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebral Hygroma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholangiocarcinoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
Chronic Myeloid Leukaemia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colon Adenoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colon Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Colon Cancer Metastatic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Colorectal Adenocarcinoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colorectal Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diffuse Large B-Cell Lymphoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastric Cancer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Glioblastoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Hodgkin's Disease
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Invasive Ductal Breast Carcinoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Large Cell Lung Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Laryngeal Cancer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lipoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lung Adenocarcinoma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
Lung Adenocarcinoma Metastatic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Lung Cancer Metastatic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lung Neoplasm Malignant
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 0 |
Lymphoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malignant Melanoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malignant Melanoma in Situ
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malignant Neoplasm of Unknown Primary Site
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mediastinum Neoplasm
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Meningioma Benign
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metastases to Central Nervous System
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metastases to Liver
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Neuroendocrine Carcinoma Metastatic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
1 / 1 |
Neuroendocrine Tumour
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Non-Hodgkin's Lymphoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Non-Small Cell Lung Cancer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Oesophageal Squamous Cell Carcinoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Ovarian Cancer Metastatic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Pancreatic Carcinoma
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 1 |
Papillary Cystadenoma Lymphomatosum
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Papillary Thyroid Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Plasma Cell Myeloma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prostate Cancer
|
|
|
subjects affected / exposed
|
8 / 2903 (0.28%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
2 / 8 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prostate Cancer Metastatic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rectal Cancer
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Cancer
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Schwannoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Serous Cystadenocarcinoma of Pancreas
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Small Cell Lung Cancer Metastatic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Squamous Cell Carcinoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Squamous Cell Carcinoma of Lung
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Squamous Cell Carcinoma of Skin
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Squamous Cell Carcinoma of the Oral Cavity
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Squamous Cell Carcinoma of the Tongue
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tongue Neoplasm Malignant Stage Unspecified
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ureteric Cancer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Cancer
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Leiomyoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular disorders
|
|
|
Aortic Aneurysm
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aortic Arteriosclerosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aortic Stenosis
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arterial Thrombosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arteriosclerosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Circulatory Collapse
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Deep Vein Thrombosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Diabetic Vascular Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Extremity Necrosis
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
1 / 5 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertension
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertensive Crisis
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypotension
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypovolaemic Shock
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Iliac Artery Occlusion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intermittent Claudication
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Orthostatic Hypotension
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
2 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Arterial Occlusive Disease
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
9 / 2904 (0.31%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Artery Occlusion
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Artery Stenosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
8 / 2904 (0.28%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Artery Thrombosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Embolism
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Ischaemia
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
7 / 2904 (0.24%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Vascular Disorder
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
9 / 2904 (0.31%) |
occurrences causally related to treatment / all
|
0 / 5 |
1 / 12 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Venous Disease
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Poor Peripheral Circulation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Post Thrombotic Syndrome
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Insufficiency
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Surgical and medical procedures
|
|
|
Coronary Arterial Stent Insertion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hospitalisation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stent Placement
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
General disorders and administration site conditions
|
|
|
Adverse Drug Reaction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac Death
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Chest Discomfort
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chest Pain
|
|
|
subjects affected / exposed
|
17 / 2903 (0.59%) |
22 / 2904 (0.76%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 22 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Complication Associated with Device
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cyst
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Death
|
|
|
subjects affected / exposed
|
7 / 2903 (0.24%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
1 / 7 |
0 / 5 |
Drug Intolerance
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gait Disturbance
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Generalised Oedema
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Impaired Healing
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Malaise
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Non-Cardiac Chest Pain
|
|
|
subjects affected / exposed
|
7 / 2903 (0.24%) |
9 / 2904 (0.31%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Oedema Peripheral
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Swelling
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyrexia
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sudden Cardiac Death
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Sudden Death
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 6 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 6 |
1 / 6 |
Vascular Stent Restenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Stent Thrombosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Immune system disorders
|
|
|
Anaphylactic Reaction
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Drug Hypersensitivity
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sarcoidosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Social circumstances
|
|
|
Penile Prosthesis User
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Victim of Homicide
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Reproductive system and breast disorders
|
|
|
Balanoposthitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Benign Prostatic Hyperplasia
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endometrial Hyperplasia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endometrial Hypertrophy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epididymal Disorder
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Erectile Dysfunction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fallopian Tube Cyst
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metrorrhagia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peyronie's Disease
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prostatitis
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prostatomegaly
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Polyp
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Uterine Prolapse
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory, thoracic and mediastinal disorders
|
|
|
Acute Pulmonary Oedema
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Acute Respiratory Distress Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Acute Respiratory Failure
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Asthma
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Asthmatic Crisis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atelectasis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchitis Chronic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchospasm
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chronic Obstructive Pulmonary Disease
|
|
|
subjects affected / exposed
|
11 / 2903 (0.38%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 26 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cough
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dyspnoea
|
|
|
subjects affected / exposed
|
8 / 2903 (0.28%) |
8 / 2904 (0.28%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epistaxis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Haemoptysis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemothorax
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypoventilation
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mediastinal Effusion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nasal Obstruction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pleural Effusion
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Pneumonia Aspiration
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Pneumothorax
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Embolism
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
Pulmonary Fibrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Pulmonary Mass
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Oedema
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Pulmonary Sarcoidosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory Acidosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory Alkalosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory Failure
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
Sleep Apnoea Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vocal Cord Leukoplakia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Psychiatric disorders
|
|
|
Bipolar Disorder
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Completed Suicide
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Confusional State
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Delirium
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Depression
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Depression Suicidal
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Emotional Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Major Depression
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Psychotic Disorder
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Suicidal Ideation
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Suicide Attempt
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Product issues
|
|
|
Device Breakage
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Device Loosening
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Device Malfunction
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Patient-Device Incompatibility
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatobiliary disorders
|
|
|
Bile Duct Stone
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Biliary Colic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholangitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholangitis Acute
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis Acute
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholelithiasis
|
|
|
subjects affected / exposed
|
7 / 2903 (0.24%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholelithiasis Obstructive
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gallbladder Polyp
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemobilia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatic Cirrhosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatic Lesion
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hydrocholecystis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Jaundice Cholestatic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Liver Injury
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Non-Alcoholic Steatohepatitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Investigations
|
|
|
Arteriogram Coronary
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blood Creatinine Increased
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blood Glucose Increased
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ejection Fraction Decreased
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Electrocardiogram QT Prolonged
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Electrocardiogram St-T Change
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Electrocardiogram T Wave Inversion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
International Normalised Ratio Increased
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Liver Function Test Increased
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Platelet Count Decreased
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
White Blood Cell Count Decreased
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Injury, poisoning and procedural complications
|
|
|
Ankle Fracture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arterial Bypass Stenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carotid Artery Restenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cataract Operation Complication
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Clavicle Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Concussion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Contusion
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Craniocerebral Injury
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
Epiphyseal Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Injury
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Facial Bones Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fall
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Femoral Neck Fracture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Femur Fracture
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fibula Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foot Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fractured Coccyx
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hand Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Head Injury
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hip Fracture
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Humerus Fracture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Jaw Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Joint Dislocation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Laceration
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ligament Sprain
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Limb Crushing Injury
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Limb Injury
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lumbar Vertebral Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Meniscus Injury
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Patella Fracture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumocephalus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Laminectomy Syndrome
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Haematoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Haematuria
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postoperative Hernia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postoperative Respiratory Failure
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Procedural Headache
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Procedural Pain
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pubis Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Radius Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rib Fracture
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Road Traffic Accident
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Spinal Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Subarachnoid Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Subdural Haematoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Suture Related Complication
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tendon Injury
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tendon Rupture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thermal Burn
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thoracic Vertebral Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tibia Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Toxicity to Various Agents
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Traumatic Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Traumatic Ulcer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ulna Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Upper Limb Fracture
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Graft Stenosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound Dehiscence
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound Necrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wrist Fracture
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac disorders
|
|
|
Acute Coronary Syndrome
|
|
|
subjects affected / exposed
|
11 / 2903 (0.38%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Left Ventricular Failure
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Acute Myocardial Infarction
|
|
|
subjects affected / exposed
|
26 / 2903 (0.90%) |
32 / 2904 (1.10%) |
occurrences causally related to treatment / all
|
0 / 31 |
1 / 35 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 6 |
Adams-Stokes Syndrome
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Angina Pectoris
|
|
|
subjects affected / exposed
|
33 / 2903 (1.14%) |
22 / 2904 (0.76%) |
occurrences causally related to treatment / all
|
0 / 34 |
0 / 24 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Angina Unstable
|
|
|
subjects affected / exposed
|
42 / 2903 (1.45%) |
42 / 2904 (1.45%) |
occurrences causally related to treatment / all
|
0 / 54 |
0 / 47 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aortic Valve Disease
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Aortic Valve Incompetence
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arrhythmia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Arteriosclerosis Coronary Artery
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrial Fibrillation
|
|
|
subjects affected / exposed
|
18 / 2903 (0.62%) |
14 / 2904 (0.48%) |
occurrences causally related to treatment / all
|
1 / 22 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrial Flutter
|
|
|
subjects affected / exposed
|
7 / 2903 (0.24%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrial Tachycardia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrioventricular Block Complete
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Atrioventricular Block Second Degree
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bradycardia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac Arrest
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 8 |
0 / 3 |
Cardiac Disorder
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac Failure
|
|
|
subjects affected / exposed
|
41 / 2903 (1.41%) |
19 / 2904 (0.65%) |
occurrences causally related to treatment / all
|
0 / 47 |
2 / 21 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 1 |
Cardiac Failure Acute
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardiac Failure Chronic
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
Cardiac Failure Congestive
|
|
|
subjects affected / exposed
|
18 / 2903 (0.62%) |
11 / 2904 (0.38%) |
occurrences causally related to treatment / all
|
0 / 25 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Cardiac Valve Disease
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cardio-Respiratory Arrest
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
Cardiogenic Shock
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Cardiopulmonary Failure
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Conduction Disorder
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Congestive Cardiomyopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Coronary Artery Disease
|
|
|
subjects affected / exposed
|
29 / 2903 (1.00%) |
34 / 2904 (1.17%) |
occurrences causally related to treatment / all
|
1 / 30 |
0 / 36 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
Coronary Artery Insufficiency
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Coronary Artery Occlusion
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Coronary Artery Stenosis
|
|
|
subjects affected / exposed
|
8 / 2903 (0.28%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Cardiomyopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Ischaemic Cardiomyopathy
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Left Ventricular Dysfunction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Left Ventricular Failure
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Mitral Valve Stenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Myocardial Fibrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Myocardial Infarction
|
|
|
subjects affected / exposed
|
24 / 2903 (0.83%) |
31 / 2904 (1.07%) |
occurrences causally related to treatment / all
|
1 / 24 |
1 / 34 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 8 |
Myocardial Ischaemia
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
7 / 2904 (0.24%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pericardial Effusion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pericarditis
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Prinzmetal Angina
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Right Ventricular Failure
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sinus Bradycardia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sinus Node Dysfunction
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Supraventricular Tachycardia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tachycardia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tricuspid Valve Incompetence
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ventricular Arrhythmia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ventricular Asystole
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Ventricular Extrasystoles
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ventricular Fibrillation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ventricular Tachycardia
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nervous system disorders
|
|
|
Basilar Artery Occlusion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Brain Injury
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Brain Stem Infarction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Brain Stem Stroke
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carotid Arteriosclerosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carotid Artery Occlusion
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carotid Artery Stenosis
|
|
|
subjects affected / exposed
|
7 / 2903 (0.24%) |
9 / 2904 (0.31%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carpal Tunnel Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebellar Infarction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebral Haematoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebral Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Cerebral Infarction
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebral Ischaemia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cerebrovascular Accident
|
|
|
subjects affected / exposed
|
37 / 2903 (1.27%) |
15 / 2904 (0.52%) |
occurrences causally related to treatment / all
|
2 / 41 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 1 |
Cervicobrachial Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cognitive Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Mononeuropathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Neuropathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dizziness Postural
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Embolic Stroke
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epilepsy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Facial Nerve Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Generalised Tonic-Clonic Seizure
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haemorrhagic Stroke
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
Headache
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hemiparesis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hydrocephalus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertensive Encephalopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypoxic-Ischaemic Encephalopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intraventricular Haemorrhage
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ischaemic Cerebral Infarction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ischaemic Stroke
|
|
|
subjects affected / exposed
|
12 / 2903 (0.41%) |
20 / 2904 (0.69%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 21 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
Lacunar Infarction
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lacunar Stroke
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lethargy
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Loss of Consciousness
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lumbar Radiculopathy
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metabolic Encephalopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Migraine
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Myasthenia Gravis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Myasthenia Gravis Crisis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nerve Compression
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Neuralgia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Paraesthesia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peripheral Nerve Paresis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Presyncope
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Radiculopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sciatica
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Seizure
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sensory Loss
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Cord Compression
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Syncope
|
|
|
subjects affected / exposed
|
8 / 2903 (0.28%) |
10 / 2904 (0.34%) |
occurrences causally related to treatment / all
|
0 / 8 |
2 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thalamic Infarction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Toxic Encephalopathy
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Transient Ischaemic Attack
|
|
|
subjects affected / exposed
|
10 / 2903 (0.34%) |
8 / 2904 (0.28%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tremor
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Trigeminal Neuralgia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Encephalopathy
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vascular Headache
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vertebral Artery Occlusion
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vertebrobasilar Insufficiency
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vocal Cord Paralysis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Blood and lymphatic system disorders
|
|
|
Anaemia
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
10 / 2904 (0.34%) |
occurrences causally related to treatment / all
|
0 / 8 |
2 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Febrile Neutropenia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Iron Deficiency Anaemia
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Polycythaemia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Thrombocytopenia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ear and labyrinth disorders
|
|
|
Haematotympanum
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypoacusis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Vertigo
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye disorders
|
|
|
Amaurosis Fugax
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cataract
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
10 / 2904 (0.34%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Retinopathy
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diplopia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Pain
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eyelid Ptosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Glaucoma
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Macular Fibrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retinal Artery Occlusion
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retinal Detachment
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Retinopathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal disorders
|
|
|
Abdominal Hernia
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain Lower
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abdominal Pain Upper
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Anal Fistula
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ascites
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Barrett's Oesophagus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bowel Movement Irregularity
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colitis Ischaemic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colitis Microscopic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colitis Ulcerative
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colonic Pseudo-Obstruction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Constipation
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diarrhoea
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diverticular Perforation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diverticulum
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diverticulum Intestinal
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Duodenal Ulcer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Duodenal Ulcer Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Duodenal Ulcer Perforation
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Enterocolitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Food Poisoning
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastric Polyps
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroduodenitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastrointestinal Haemorrhage
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematemesis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ileus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Impaired Gastric Emptying
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Inguinal Hernia
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intestinal Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intestinal Ischaemia
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
Intestinal Obstruction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intestinal Ulcer Perforation
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Large Intestine Perforation
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Lower Gastrointestinal Haemorrhage
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Melaena
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mesenteric Arterial Occlusion
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mesenteric Vein Thrombosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Oesophageal Obstruction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pancreatitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pancreatitis Acute
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peptic Ulcer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumoperitoneum
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rectal Tenesmus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Salivary Gland Calculus
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
Salivary Gland Fistula
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Small Intestinal Obstruction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Swollen Tongue
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tooth Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Umbilical Hernia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Upper Gastrointestinal Haemorrhage
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Volvulus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin and subcutaneous tissue disorders
|
|
|
Angioedema
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dermatitis Allergic
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Foot
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
10 / 2904 (0.34%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Ulcer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin Fissures
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin Necrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Skin Ulcer
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
7 / 2904 (0.24%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urticaria
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal and urinary disorders
|
|
|
Acute Kidney Injury
|
|
|
subjects affected / exposed
|
15 / 2903 (0.52%) |
7 / 2904 (0.24%) |
occurrences causally related to treatment / all
|
2 / 17 |
3 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 2 |
Bladder Obstruction
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Chronic Kidney Disease
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Diabetic Nephropathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Haematuria
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hydronephrosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ketonuria
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nephrolithiasis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
8 / 2904 (0.28%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nephropathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nephropathy Toxic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Nephrotic Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pelvi-Ureteric Obstruction
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pollakiuria
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Proteinuria
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Colic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Failure
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Haematoma
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Renal Impairment
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Renal Injury
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
2 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stress Urinary Incontinence
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tubulointerstitial Nephritis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ureterolithiasis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urethral Stenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Incontinence
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Retention
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endocrine disorders
|
|
|
Basedow's Disease
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperparathyroidism
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperparathyroidism Primary
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperthyroidism
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Musculoskeletal and connective tissue disorders
|
|
|
Arthralgia
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthritis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthropathy
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Back Pain
|
|
|
subjects affected / exposed
|
11 / 2903 (0.38%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bursitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cervical Spinal Stenosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Costochondritis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dactylitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dupuytren's Contracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Extremity Contracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Foot Deformity
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intervertebral Disc Compression
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intervertebral Disc Disorder
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intervertebral Disc Protrusion
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
7 / 2904 (0.24%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Knee Deformity
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lumbar Spinal Stenosis
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Muscular Weakness
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Musculoskeletal Chest Pain
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Musculoskeletal Pain
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteoarthritis
|
|
|
subjects affected / exposed
|
16 / 2903 (0.55%) |
13 / 2904 (0.45%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteonecrosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pathological Fracture
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Plantar Fasciitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Polymyalgia Rheumatica
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rhabdomyolysis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Rotator Cuff Syndrome
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sacroiliitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Column Stenosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Osteoarthritis
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spinal Pain
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Spondylolisthesis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Synovial Cyst
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tendonitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tenosynovitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tenosynovitis Stenosans
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Trigger Finger
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infections and infestations
|
|
|
Abscess
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Limb
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Abscess Neck
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Appendicitis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Arthritis Bacterial
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Bronchitis
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Campylobacter Gastroenteritis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Carbuncle
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cellulitis
|
|
|
subjects affected / exposed
|
11 / 2903 (0.38%) |
9 / 2904 (0.31%) |
occurrences causally related to treatment / all
|
0 / 14 |
1 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cellulitis Staphylococcal
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cellulitis Streptococcal
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cholecystitis Infective
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Colonic Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Device Related Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Foot Infection
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Gangrene
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diverticulitis
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Ear Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Empyema
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Endocarditis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Epididymitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Erysipelas
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Escherichia Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Escherichia Sepsis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Escherichia Urinary Tract Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Eye Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gangrene
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroenteritis
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
8 / 2904 (0.28%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gastroenteritis Viral
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Genital Infection Fungal
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hepatitis B
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Herpes Zoster
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hiv Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infected Dermal Cyst
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infected Skin Ulcer
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Infective Exacerbation of Chronic Obstructive Airways Disease
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Influenza
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Intervertebral Discitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Laryngitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Localised Infection
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lower Respiratory Tract Infection
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lung Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Mastoiditis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Orchitis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteomyelitis
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 6 |
2 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Osteomyelitis Chronic
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Otitis Media Acute
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Parasitic Gastroenteritis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Paronychia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pelvic Abscess
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Penile Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Perinephric Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Peritonsillar Abscess
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pharyngotonsillitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumococcal Sepsis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumonia
|
|
|
subjects affected / exposed
|
31 / 2903 (1.07%) |
26 / 2904 (0.90%) |
occurrences causally related to treatment / all
|
1 / 33 |
0 / 27 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 5 |
Pneumonia Legionella
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pneumonia Pneumococcal
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Infection
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Post Procedural Sepsis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Postoperative Wound Infection
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pulmonary Sepsis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
Pulmonary Tuberculosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyelonephritis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 2 |
3 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Pyelonephritis Acute
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Respiratory Tract Infection
|
|
|
subjects affected / exposed
|
13 / 2903 (0.45%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Scrotal Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Scrotal Infection
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Sepsis
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 0 |
Septic Shock
|
|
|
subjects affected / exposed
|
6 / 2903 (0.21%) |
4 / 2904 (0.14%) |
occurrences causally related to treatment / all
|
1 / 6 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 2 |
Sinusitis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Soft Tissue Infection
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Staphylococcal Infection
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Staphylococcal Sepsis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Stenotrophomonas Infection
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Subcutaneous Abscess
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tooth Abscess
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tooth Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Tracheobronchitis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Upper Respiratory Tract Infection
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Tract Infection
|
|
|
subjects affected / exposed
|
13 / 2903 (0.45%) |
11 / 2904 (0.38%) |
occurrences causally related to treatment / all
|
6 / 13 |
4 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urinary Tract Infection Enterococcal
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Urosepsis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Wound Infection
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Metabolism and nutrition disorders
|
|
|
Acidosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Cachexia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Dehydration
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
2 / 2 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetes Mellitus
|
|
|
subjects affected / exposed
|
18 / 2903 (0.62%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 19 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetes Mellitus Inadequate Control
|
|
|
subjects affected / exposed
|
12 / 2903 (0.41%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Complication
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Diabetic Ketoacidosis
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 2 |
5 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Electrolyte Imbalance
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Fluid Overload
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Gout
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperglycaemia
|
|
|
subjects affected / exposed
|
11 / 2903 (0.38%) |
5 / 2904 (0.17%) |
occurrences causally related to treatment / all
|
0 / 11 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperkalaemia
|
|
|
subjects affected / exposed
|
5 / 2903 (0.17%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
2 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyperosmolar Hyperglycaemic State
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypertriglyceridaemia
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypoglycaemia
|
|
|
subjects affected / exposed
|
9 / 2903 (0.31%) |
6 / 2904 (0.21%) |
occurrences causally related to treatment / all
|
2 / 10 |
2 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypokalaemia
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
0 / 2904 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hyponatraemia
|
|
|
subjects affected / exposed
|
4 / 2903 (0.14%) |
3 / 2904 (0.10%) |
occurrences causally related to treatment / all
|
3 / 5 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Hypovolaemia
|
|
|
subjects affected / exposed
|
2 / 2903 (0.07%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Lactic Acidosis
|
|
|
subjects affected / exposed
|
0 / 2903 (0.00%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
Metabolic Acidosis
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Obesity
|
|
|
subjects affected / exposed
|
3 / 2903 (0.10%) |
2 / 2904 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
Type 2 Diabetes Mellitus
|
|
|
subjects affected / exposed
|
1 / 2903 (0.03%) |
1 / 2904 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |